Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

Response evaluation and survival prediction following PD-1 immunotherapy in patients with non-small-cell lung cancer: comparison of assessment methods.

Narjess Ayati, Sze Ting Lee, Seyed Rasoul Zakavi, Melissa Cheng, Eddie Lau, Sagun Parakh, Kunthi Pathmaraj and Andrew Scott
Journal of Nuclear Medicine November 2020, jnumed.120.254508; DOI: https://doi.org/10.2967/jnumed.120.254508
Narjess Ayati
1 Austin Health, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sze Ting Lee
2 Austin Hospital, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sze Ting Lee
Seyed Rasoul Zakavi
3 Mashad University of Medical Sciences, Iran, Islamic Republic of;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa Cheng
1 Austin Health, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eddie Lau
1 Austin Health, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sagun Parakh
4 Olivia Newton-John Cancer Research Institute, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kunthi Pathmaraj
1 Austin Health, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Scott
5 Austin Health and Olivia Newton-John Cancer Research Institute, La Trobe University and Melbourne University, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew Scott
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.120.254508
DOI 
https://doi.org/10.2967/jnumed.120.254508
PubMed 
33246978

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 27, 2020.

Article Versions

  • You are currently viewing a previous version of this article (November 27, 2020 - 13:56).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2020 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Narjess Ayati1,
  2. Sze Ting Lee2,
  3. Seyed Rasoul Zakavi3,
  4. Melissa Cheng1,
  5. Eddie Lau1,
  6. Sagun Parakh4,
  7. Kunthi Pathmaraj1 and
  8. Andrew Scott5
  1. 1 Austin Health, Australia;
  2. 2 Austin Hospital, Australia;
  3. 3 Mashad University of Medical Sciences, Iran, Islamic Republic of;
  4. 4 Olivia Newton-John Cancer Research Institute, Australia;
  5. 5 Austin Health and Olivia Newton-John Cancer Research Institute, La Trobe University and Melbourne University, Australia
  1. For correspondence or reprints contact: Andrew Scott, Austin Health and Olivia Newton-John Cancer Research Institute, La Trobe University and Melbourne University, Studley Rd, Heidelberg, VIC 3084, Australia. E-mail: andrew.scott@austin.org.au

Statistics from Altmetric.com

Cited By...

  • 21 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Cuproptosis: mechanisms and links with cancers
    Jiaming Xie, Yannan Yang, Yibo Gao, Jie He
    Molecular Cancer 2023 22 1
  • [18F]FDG-PET/CT Radiomics and Artificial Intelligence in Lung Cancer: Technical Aspects and Potential Clinical Applications
    Reyhaneh Manafi-Farid, Emran Askari, Isaac Shiri, Christian Pirich, Mahboobeh Asadi, Maziar Khateri, Habib Zaidi, Mohsen Beheshti
    Seminars in Nuclear Medicine 2022 52 6
  • Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [18F]FDG PET/CT in Metastatic Melanomas and Lung Cancer
    Egesta Lopci
    Journal of Clinical Medicine 2021 10 21
  • The Value of the Standardized Uptake Value (SUV) and Metabolic Tumor Volume (MTV) in Lung Cancer
    Rodney J. Hicks
    Seminars in Nuclear Medicine 2022 52 6
  • IL-9 Producing Tumor-Infiltrating Lymphocytes and Treg Subsets Drive Immune Escape of Tumor Cells in Non-Small Cell Lung Cancer
    Lisanne Heim, Zuqin Yang, Patrick Tausche, Katja Hohenberger, Mircea T. Chiriac, Julia Koelle, Carol-Immanuel Geppert, Katerina Kachler, Sarah Miksch, Anna Graser, Juliane Friedrich, Rakshin Kharwadkar, Ralf J. Rieker, Denis I. Trufa, Horia Sirbu, Markus F. Neurath, Mark H. Kaplan, Susetta Finotto
    Frontiers in Immunology 2022 13
  • Immune-related dissociated response as a specific atypical response pattern in solid tumors with immune checkpoint blockade
    Yaping Guan, Dongfeng Feng, Beibei Yin, Kun Li, Jun Wang
    Therapeutic Advances in Medical Oncology 2022 14
  • Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria
    Meng Zhou, Chunhui Zhang, Jianhua Nie, Yajuan Sun, Ye Xu, Fangfang Wu, Yuhong Huang, Shun Li, Yuan Wang, Yang Zhou, Tongsen Zheng
    Frontiers in Oncology 2021 11
  • Four-dimensional quantitative analysis using FDG-PET in clinical oncology
    Nagara Tamaki, Kenji Hirata, Tomoya Kotani, Yoshitomo Nakai, Shigenori Matsushima, Kei Yamada
    Japanese Journal of Radiology 2023 41 8
  • Generative models improve radiomics performance in different tasks and different datasets: An experimental study
    Junhua Chen, Inigo Bermejo, Andre Dekker, Leonard Wee
    Physica Medica 2022 98
  • The role of PET molecular imaging in immune checkpoint inhibitor therapy in lung cancer: Precision medicine and visual monitoring
    Yuan Yao, Xin Zhou, Annan Zhang, Xiaopan Ma, Hua Zhu, Zhi Yang, Nan Li
    European Journal of Radiology 2022 149

Article usage

Article usage: November 2020 to April 2025

AbstractFullPdf
Nov 2020258019
Dec 2020631055
Jan 2021296012
Feb 2021241016
Mar 2021239012
Apr 2021263016
May 2021353021
Jun 2021160082
Jul 20211272117152
Aug 20214052241
Sep 20213761037
Oct 2021262978
Nov 2021361727
Dec 2021240824
Jan 2022774535
Feb 2022346831
Mar 2022385063
Apr 2022245982
May 2022165553
Jun 2022206248
Jul 2022184327
Aug 2022224534
Sep 2022163332
Oct 202275729
Nov 2022125932
Dec 2022183225
Jan 2023123226
Feb 2023133426
Mar 2023102220
Apr 2023102323
May 202372018
Jun 2023152624
Jul 202352726
Aug 2023121830
Sep 2023112218
Oct 202353023
Nov 2023142216
Dec 202353027
Jan 2024365522
Feb 202482224
Mar 202452538
Apr 202484435
May 202483015
Jun 2024165427
Jul 2024129429
Aug 202489229
Sep 2024624141
Oct 20241027141
Nov 2024102617
Dec 2024103940
Jan 202574431
Feb 20251110247
Mar 2025119531
Apr 2025327255
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Response evaluation and survival prediction following PD-1 immunotherapy in patients with non-small-cell lung cancer: comparison of assessment methods.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Response evaluation and survival prediction following PD-1 immunotherapy in patients with non-small-cell lung cancer: comparison of assessment methods.
Narjess Ayati, Sze Ting Lee, Seyed Rasoul Zakavi, Melissa Cheng, Eddie Lau, Sagun Parakh, Kunthi Pathmaraj, Andrew Scott
Journal of Nuclear Medicine Nov 2020, jnumed.120.254508; DOI: 10.2967/jnumed.120.254508

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Response evaluation and survival prediction following PD-1 immunotherapy in patients with non-small-cell lung cancer: comparison of assessment methods.
Narjess Ayati, Sze Ting Lee, Seyed Rasoul Zakavi, Melissa Cheng, Eddie Lau, Sagun Parakh, Kunthi Pathmaraj, Andrew Scott
Journal of Nuclear Medicine Nov 2020, jnumed.120.254508; DOI: 10.2967/jnumed.120.254508
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • The added value of 18F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer
Show more Clinical Investigations (Human)

Clinical (Oncology: Lung)

  • First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer Patients
  • Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
Show more Clinical (Oncology: Lung)

Similar Articles

Keywords

  • Correlative Imaging
  • Oncology: Lung
  • PET/CT
  • PD-1 inhibitor
  • PERCIST
  • imPERCIST
  • non small-cell lung cancer
SNMMI

© 2025 SNMMI

Powered by HighWire